CeriBell, Inc (CBLL) — Quality & forensics
As of 2026-10-19 — refreshed nightly. Closelooknet readings from an investment research diary, not ratings or advice.
The Closelooknet module scores
- Valuation 16
- Quality 22
- Growth 69
- Balance sheet 62
- Cash quality 52
- Capital allocation 16
- Momentum 84
Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.
Financial forensics — the academic screens
Sits in the safe zone (above 2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.
Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.
Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.
Continue: the CBLL chart & overview
FAQ · from the current data · as of 2026-10-19
Quick answers
What is CeriBell, Inc's Closelooknet quality reading?
The composite reads 45/100 across 7 modules, as of 2026-10-19: valuation 16, quality 22, growth 69, balance sheet 62, cash quality 52, capital allocation 16, momentum 84. Closelooknet scores are research diary readings, not ratings or investment advice.
What is CeriBell, Inc's Altman Z-Score?
13.17, which sits in the safe zone (above 2.99) as of 2026-10-19. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.
What is CeriBell, Inc's Piotroski F-Score?
3 of 9, as of 2026-10-19. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.
What does CeriBell, Inc's Beneish M-Score indicate?
-2.57 — below the −1.78 manipulation-risk threshold, as of 2026-10-19. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.
Related in the Closelooknet universe
then Medical Devices, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- DXCM Dexcomindustry
- SECT-B.ST Sectraindustry
- GMED Globus Medicalindustry
- SNN Smith & Nephew SNATS Incindustry
- SOON.SW Sonovaindustry
- SYK Strykerindustry
- CEVI.ST CellaVisionindustry
- HALO Halozyme Therapeutics Incsector
- ONC BeiGene, Ltd.sector
- MEDP Medpace Holdings Incsector
- RIGL Rigel Pharmaceuticals Incsector
- BTSG BTSG.USsector
- APGE APGE.USsector
- ALKS ALKS.USsector
- ASND ASND.USsector
- BBIO BBIO.USsector
- ARGX ARGX.USsector
- AXSM AXSM.USsector
- ARWR ARWR.USsector
- CGEM CGEM.USsector